Generic Name: Formoterol + Tiotropium
Brand: Duova
Company: Cipla Ltd.
Dosage Form: Metered Dose Inhaler (MDI)
Pack Size: 120 metered doses
Composition
Each actuation (puff) delivers:
-
Formoterol Fumarate Dihydrate 6 mcg (Long-acting Beta-2 Agonist – LABA)
-
Tiotropium Bromide 9 mcg (Long-acting Anticholinergic – LAMA)
-
Propellant & excipients
Category
-
Bronchodilator (Combination)
-
LABA + LAMA
-
Used mainly for maintenance therapy in COPD
Uses / Indications
Duova Inhaler is prescribed for long-term treatment of:
-
Chronic Obstructive Pulmonary Disease (COPD)
-
Chronic bronchitis & emphysema
-
Maintenance therapy for airflow obstruction, wheezing, and breathlessness
(Not usually prescribed for asthma unless advised by doctor)
How It Works
-
Formoterol → relaxes airway smooth muscles, provides bronchodilation for up to 12 hours.
-
Tiotropium → blocks muscarinic receptors → prevents airway narrowing.
-
Together → provide dual long-acting bronchodilation, improving lung function & easing breathing.
Dosage (General Guide – only as prescribed by doctor)
-
Adults: 2 inhalations once daily.
-
Not recommended for children under 18 years.
-
Not for sudden asthma/COPD attacks → rescue inhaler should be used separately.
How to Use
-
Shake inhaler before use.
-
Exhale fully, place mouthpiece between lips.
-
Press canister while inhaling deeply.
-
Hold breath for 5–10 seconds, then exhale.
-
Rinse mouth after use.
Side Effects
Common: Dry mouth, cough, sore throat, headache, tremors, dizziness.
Serious (rare): Chest pain, irregular heartbeat, eye pain/blurred vision, allergic reaction, worsening breathing.
Precautions & Warnings
-
Not for acute asthma/COPD attacks.
-
Use with caution in heart disease, glaucoma, prostate problems, thyroid disorders, diabetes.
-
Rinse mouth after use to avoid throat irritation.
-
Use in pregnancy & breastfeeding only if prescribed.
Storage
-
Store below 30°C, away from direct heat & sunlight.
-
Do not puncture or burn even when empty.
-
Keep out of reach of children.
Reviews
There are no reviews yet.